Speakers

The largest and most detailed biosimilars event presents the speaking faculty for the 13th Annual Business of Biosimilars and Generic Drugs.

Abdullah Baaj, CEO, BOSTON ONCOLOGY
Aaron Barkoff, Partner, McANDREWS, HELD, & MALLOY LTD
Michael Bauer, IP Counsel, HOSPIRA
Richard Brudnick, VP, Business Development, BIOGEN IDEC
Alex Bruni, VP for Commercial Operations, MERZ PHARMACEUTICALS
Carrie Burke, Director of Government Affairs, SHIRE
G. Steven Burrill, CEO, BURRILL & COMPANY
Michael Castagna, Executive Director of Immunoscience, BRISTOL-MYERS SQUIBB
ShinJae Chang, VP for R&D, CELLTRION
Bassil Dahiyat, President and CEO, XENCOR
Richard DiCicco, Chairman, HARVEST MOON PHARMACEUTICALS
Hoss Dowlat, Vice President – Regulatory Affairs, PHARMA-BIO CONSULTING
Candis Edwards, Senior Director, Regulatory Affairs & Compliance, AMNEAL PHARMACEUTICALS
Thomas Felix, Director, Scientific Affairs, Biosimilars Lead, AMGEN
Mitchell Goldberg, VP, Sales & Marketing, SIGMAPHARM LABORATORIES
Steven Goldberg, Chief of Medical Affairs, EXPRESS SCRIPTS
Brian Harvey, Vice President, U.S. Regulatory Strategy, PFIZER
Shmulik Hess, Director, VANIR BIO
Mark Hyman, Assistant General Counsel, Litigation & IP, HUMAN GENOME SCIENCES
Bruce Leicher, Senior VP and General Counsel, MOMENTA
Magdalena Leszczniecka, CEO, STC BIOLOGICS
Steven Lucio, Director, Pharmacy Clinical Services, NOVATION
Suzanne Munck, Chief Counsel for Intellectual Property, FTC
Hans Sauer, Associate General Counsel for IP, BIO
Suzanne Sensabaugh, Founder, HARTMANN WILLNER LLC
Andrew Shaw, Senior Director, PKDM, MYLAN